Abstract
Hypertension represents a major burden in Asia, with a high prevalence rate but poor level of awareness and control reported in many countries in the region. Home blood pressure monitoring has been validated as an accurate and reliable measure of blood pressure that can help guide hypertension treatment as well as identify masked and white-coat hypertension. Despite its benefits, there has been limited research into home blood pressure monitoring in Asia. The authors reviewed the current evidence on home blood pressure monitoring in Asia, including but not limited to published literature, data presented at congresses, and national hypertension management guidelines to determine the current utilization of home blood pressure monitoring in clinical practice in the region. Public policies to enable greater access to home blood pressure monitoring and its use in clinical care would add considerably to improving hypertension outcomes in Asia.
| Original language | English |
|---|---|
| Pages (from-to) | 1192-1201 |
| Number of pages | 10 |
| Journal | Journal of Clinical Hypertension |
| Volume | 19 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2017 Nov |
Bibliographical note
Funding Information:This statement on blood pressure measurement is supported by the World Hypertension League.
Funding Information:
Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer.
Funding Information:
Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer.
Publisher Copyright:
©2017 Wiley Periodicals, Inc.
All Science Journal Classification (ASJC) codes
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Cardiology and Cardiovascular Medicine
